Clinical Trial Update: A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac Angiography [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing two iodinated contrast agents in renally impaired patients undergoing cardiac angiography has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Drugs mentioned

• Iodinated contrast agent A
• Iodinated contrast agent B

Snippet

Sponsor: Bracco Diagnostics, Inc | Conditions: CIN | Phase 4 | Status: COMPLETED